CD274 and neoplasm: In summary, our work apparently demonstrated that glycosylation pattern was significantly correlated with tumor immune phenotypes and response to immunotherapy in pancancer anti‐PD‐L1 datasets, highlighting the clinical importance of glycogene signature in planning treatment strategy for CRC patients.